
Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients
Keywords: شیمی درمانی ضد سرطان; Adverse pulmonary reaction; Anticancer chemotherapy; Rituximab; Cetuximab; Trastuzumab; BevacizumabEGFR, epidermal growth factor receptor; ILD, interstitial lung disease; NHL, non-Hodgkin’s lymphoma; mAbs, monoclonal antibodies; VEGF, vascular endothelial